{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T06:43:07Z","timestamp":1788158587260,"version":"build-2803163510"},"reference-count":32,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Psycho-Oncology"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>The aim of this study is to gain insight into the physical, psychological and social impact of having a myeloproliferative neoplasm (MPN), a rare type of cancer with an often chronic course.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An online survey was conducted among 455 Dutch MPN patients (62.7% female, age <jats:italic>M<\/jats:italic> 63) to explore the impact of the disease by measuring the MPN symptom burden (MPN\u2010SAF TSS) and quality of life (QoL) (EORTC QLQ\u2010C30) and its subscales within a hierarchical QoL model. We examined differences in MPN symptom burden and QoL in relation to sociodemographic and disease\u2010related factors. Hierarchical regression analysis was used to explain variances in QoL.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Most patients (97%) experienced MPN\u2010related health complaints, with a significantly higher MPN symptom burden in women (<jats:italic>M<\/jats:italic> 31.50) compared to men (<jats:italic>M<\/jats:italic> 24.10). Regarding to fatigue and cognitive functioning MPN patients suffered more compared to a reference group of other cancers. MPN subtype or type of treatment did not show significant differences in MPN symptom burden or QoL. However, experiencing side effects, complications or comorbidities significantly negatively affected MPN symptom burden and QoL. 48.8% of patients reported that MPN affected their ability to work. The explained variance in overall QoL was 58%, most importantly by disease progression, comorbidities, MPN symptom burden and role, emotional and social functioning.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study revealed that having an MPN has a negative impact on several domains of QoL. Symptom assessment and support should be included in the healthcare management of MPN patients.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pon.6338","type":"journal-article","created":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T04:34:53Z","timestamp":1712982893000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The personal impact of living with a myeloproliferative neoplasm"],"prefix":"10.1002","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0378-6757","authenticated-orcid":false,"given":"A. A. M.","family":"Eppingbroek","sequence":"first","affiliation":[{"name":"Faculty of Psychology Open Universiteit  Heerlen the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lechner","sequence":"additional","affiliation":[{"name":"Faculty of Psychology Open Universiteit  Heerlen the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. C.","family":"Bakker","sequence":"additional","affiliation":[{"name":"Faculty of Psychology Open Universiteit  Heerlen the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. D.","family":"Nijkamp","sequence":"additional","affiliation":[{"name":"Faculty of Psychology Open Universiteit  Heerlen the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"de Witte","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht Department of Hematology  Utrecht the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A. W.","family":"Bolman","sequence":"additional","affiliation":[{"name":"Faculty of Psychology Open Universiteit  Heerlen the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,4,12]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885\u2010016\u20102208\u20102"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102014\u201005\u2010577635"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.5045\/br.2014.49.4.211"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2017.06.010"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404955"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325\u2010020\u201001314\u20100"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation\u20102017.1.480"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00761\u2010019\u20100576\u20103"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277\u2010017\u20103082\u2010y"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.42.1925"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10552\u2010021\u201001521\u20102"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899\u2010022\u201000672\u20106"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899\u2010014\u20100228\u2010z"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225666"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25270"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.2147\/clep.s162688"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.315"},{"key":"e_1_2_9_19_1","unstructured":"vanNispenR RijkenP HeijmansM ZiekenPC WeesgeneesmiddelenS.Leven Met Een Zeldzame Chronische Aandoening."},{"key":"e_1_2_9_20_1","unstructured":"BaandersA CalsbeekH SpreeuwenbergP RijkenP.Pati\u00ebntenpanel Chronisch Zieken: Kerngegevens 2001\/2002;2003."},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.4314\/gmj.v54i3.7"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24098"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.149559"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.42.3863"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102013\u201009\u2010527903"},{"key":"e_1_2_9_26_1","volume-title":"Quality of life and pharmacoeconomics in clinical trials","author":"Spilker R","year":"1996"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:QURE.0000025599.74923.f2"},{"key":"e_1_2_9_29_1","first-page":"57","volume-title":"Gezondheidspsychologie Bij Patienten","author":"Ranchor A","year":"2010"},{"key":"e_1_2_9_30_1","unstructured":"FayersPM AaronsonN BjordalK.EORTC QLQ\u2010C30 Scoring Manual2001."},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00482\u2010011\u20101143\u2010z"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277\u2010023\u201005296\u20101"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hs9.0000851064.99356.34"}],"container-title":["Psycho-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pon.6338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T02:07:43Z","timestamp":1714010863000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pon.6338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1002\/pon.6338"],"URL":"https:\/\/doi.org\/10.1002\/pon.6338","archive":["Portico"],"relation":{},"ISSN":["1057-9249","1099-1611"],"issn-type":[{"value":"1057-9249","type":"print"},{"value":"1099-1611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"2023-12-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e6338"}}